Advisory Board
HIV
Dr Michael Youle
Since 1996 he has been the Director of HIV Clinical Research at London’s Royal Free Hospital. In 2010 he founded JUSTRI, www.justri.org, a not-for-profit organization which educates and provides resources to improve HIV, viral hepatitis and tuberculosis (TB) care in many regions, including South East Europe, the Middle East and North Africa and India. His professional activities currently include a visiting professorship at Belgrade University, Serbia and board/committee memberships for various organizations such as the European AIDS Clinical Society (EACS) and the Elton John AIDS Foundation.
Thembi Mayo
Thembi has been a nurse in the NHS for 16 years, 13 of which in HIV/Sexual health, currently at Lewisham hospital She also undertakes Community work with THT and helps as a pillar of our NURSETRI work.
Dr, Laura Waters
Jane Bruton
She has a Masters in Medical Anthropology and worked with HIV patients in rural Uganda before the availability of ART. She has extensive experience in teaching in many different settings and has worked with NURSETRI for 4 years. Jane co-authored the NHIVNA Competencies and the Nurses Sexual Health Competencies and is a Trustee for Positively UK. Her main areas of experience and interest are the development of nursing roles in HIV (task shifting), patient engagement and involvement and nursing in general.
She is involved in the development of HIV and viral hepatitis guidelines with several national and European organizations as well as for the World Health Organization. She also acts as a consultant for the Medicine Patent Pool under the auspices of UNITAID and is a member of the scientific advisory board of UNAIDS.
Dr. Tristan Barber
HEPATITIS
Dr. Sanjay Bhagani
He is the head of the multi-disciplinary HIV/hepatitis co-infection service at the Royal Free, a tertiary referral service for all aspects of HIV/viral hepatitis ranging from access to phase 2/3 clinical trials for new agents to joint liver transplant assessment and post-transplant care.
His research interests include epidemiological, virological and clinical aspects of acute HCV amongst HIV+ MSM, use of non-invasive tests for liver assessment in resource-rich and resource-limited settings, implementation and clinical research in the management of viral hepatitis and HIV co-infection in resource-limited settings and clinical trials for new agents for treating HCV and HBV.
Sanjay is the current chair of the BHIVA Viral Hepatitis group and serves on the HIV/hepatitis guidelines committee for BHIVA and the EACS. He is also on the Editorial boards of AIDS Therapy and Research and BMC Hepatology, Medicine and Policy and is a trustee at AIDS Orphan. He has a passion for teaching and is currently on the steering committee for the EACS Advance HIV course and a member of the board of examiners for the Diploma in HIV Medicine, UK.
Dr. Alison Rodger
Her clinical interest is in co-infections with HIV, and with Dr Bhagani she runs the viral hepatitis/HIV clinic at the Royal Free.
Alison is a co-author of BHIVA guidelines on hepatitis co-infection, immunisations, and post-exposure prophylaxis.
She co-chairs the BHIVA/BASHH guideline writing group for PrEP. Her academic pursuits are in HIV transmission, HIV testing and prevention.
Dr Patrick Ingiliz
His main fields of interest are in HIV infection and co-infection with viral hepatitis and his clinical research focuses on acute HCV infection, liver fibrosis progression and steatohepatitis in HIV infection. He is actively involved in numerous trials studying direct-acting antiviral agents in HIV/HCV co-infected patients as well as mono-infected patients. A national and international collaborator, Dr Ingiliz has also worked as part of a HIV/AIDS programme in sub-Saharan Africa which aimed to implement antiretroviral therapy in Malawi.
Dr. Karine Lacombe
She is involved in the development of HIV and viral hepatitis guidelines with several national and European organizations as well as for the World Health Organization. She also acts as a consultant for the Medicine Patent Pool under the auspices of UNITAID and is a member of the scientific advisory board of UNAIDS.
Prof Geoffrey Dusheiko
His research interests include the management and treatment of HCV and HBV and small hepatocellular carcinoma; he has a special interest in research on viral hepatitis, especially viral genotyping, applied molecular virology, the natural history of chronic viral hepatitis and antiviral therapies. A member of several organisations, including EASL, AASLD and IASL, Professor Dusheiko is also a Fellow of the Royal Colleges of Physicians of London Edinburgh and South Africa. He advises the UK National Institute of Health and Care Excellence, and is an author of the World Health Organization’s HCV guidelines.
A member of the editorial board of the Journal of Viral Eradication, he is Co-editor of Alimentary Pharmacology and Therapeutics, and has previously served on editorial boards for the Journal of Viral Hepatitis, Hepatology, Best Practice & Research Clinical Gastroenterology, and Gut among others. Professor Dusheiko has authored or co-authored more than 350 articles in international peer-reviewed journals or books.
TB
Dr Marc Lipman
He is the former Co-lead for TB in London and Chair of the British Thoracic Society TB Specialist Advisory Group. His research interests focus on tuberculosis, HIV and respiratory disease seeking to enable high quality, evidence-based care to be provided to people at risk of TB and other related diseases. He is currently involved in a wide variety of translational and health services research programmes across the UK.